Hospital
ST Vincents Blount
ST Vincents Blount was paid $1.10M by Medicaid between Jan 2018 and Nov 2024, across 36 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.
33Billing provider infoST VINCENTS BLOUNT
ONEONTA, AL 35121
ONEONTA, AL 35121
33aNPI1184967523assigned 04/04/2013
33bProvider typeCritical Access Hospital
28Total paid$1.10M
24GClaims23,499
24DCodes billed36
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,158 | $134K | |
| 2019 | 3,591 | $136K | |
| 2020 | 2,464 | $88K | |
| 2021 | 3,236 | $139K | |
| 2022 | 4,372 | $245K | |
| 2023 | 4,461 | $260K | |
| 2024incomplete | 2,217 | $98K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 6,992 | 6,682 | $295K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 26% | 4,145 | 3,894 | $282K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21% | 999 | 921 | $236K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 13% | 1,372 | 1,318 | $147K |
| 80053 | Comprehensive metabolic panel | 2.6% | 2,789 | 2,585 | $29K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.6% | 573 | 552 | $29K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.4% | 3,187 | 2,945 | $27K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.0% | 552 | 535 | $22K |
| 87634 | <1% | 145 | 142 | $9K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 143 | 138 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 223 | 214 | $3K |
| 87070 | <1% | 248 | 242 | $3K |
24 more codes
| 71045 | Radiologic examination, chest; single view | <1% | 414 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 114 | $1K |
| 81001 | <1% | 372 | $1K | |
| 80061 | Lipid panel | <1% | 52 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 20 | $1K |
| 83735 | <1% | 114 | $842.68 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 89 | $762.10 |
| 84484 | <1% | 73 | $547.85 | |
| 83690 | <1% | 78 | $520.44 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 12 | $473.99 |
| 81025 | <1% | 109 | $423.86 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 12 | $269.94 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 118 | $158.02 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $146.76 |
| 84439 | <1% | 12 | $146.52 | |
| 85610 | <1% | 12 | $63.47 | |
| 85027 | <1% | 16 | $59.07 | |
| 85730 | <1% | 12 | $32.12 | |
| 81003 | <1% | 13 | $26.32 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 78 | $23.60 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 61 | $2.58 |
| 36415 | Collection of venous blood by venipuncture | 0% | 27 | $0.00 |
| A9270 | Non-covered item or service | 0% | 294 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHUGHES, SCOTT (CFO)
| Provider | Location | Paid |
|---|---|---|
| ST. Vincent's Blount | Oneonta, AL | $1.88M |
| ST. Vincent's Blount | Cleveland, AL | $405K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.